Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
Total Receivables
Prestige Consumer Healthcare Inc
Total Receivables Peer Comparison
Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
Total Receivables
$174.3m
|
CAGR 3-Years
15%
|
CAGR 5-Years
4%
|
CAGR 10-Years
10%
|
|
Johnson & Johnson
NYSE:JNJ
|
Total Receivables
$14.9B
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Total Receivables
$14.1B
|
CAGR 3-Years
18%
|
CAGR 5-Years
20%
|
CAGR 10-Years
17%
|
|
Pfizer Inc
NYSE:PFE
|
Total Receivables
$15.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
10%
|
CAGR 10-Years
5%
|
|
Merck & Co Inc
NYSE:MRK
|
Total Receivables
$12.1B
|
CAGR 3-Years
14%
|
CAGR 5-Years
10%
|
CAGR 10-Years
5%
|
|
Eli Lilly and Co
NYSE:LLY
|
Total Receivables
$10B
|
CAGR 3-Years
15%
|
CAGR 5-Years
14%
|
CAGR 10-Years
10%
|
See Also
What is Prestige Consumer Healthcare Inc's Total Receivables?
Total Receivables
174.3m
USD
Based on the financial report for Dec 31, 2023, Prestige Consumer Healthcare Inc's Total Receivables amounts to 174.3m USD.
What is Prestige Consumer Healthcare Inc's Total Receivables growth rate?
Total Receivables CAGR 10Y
10%
Over the last year, the Total Receivables growth was 11%. The average annual Total Receivables growth rates for Prestige Consumer Healthcare Inc have been 15% over the past three years , 4% over the past five years , and 10% over the past ten years .